标题
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-10
DOI
10.1038/s41573-019-0035-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
- (2019) Olga L. Rojas et al. CELL
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
- (2019) J. William L. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
- (2019) Yvonne Naegelin et al. JAMA Neurology
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
- (2019) Dmitri Lodygin et al. NATURE
- Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors
- (2019) Kelsey A. Rankin et al. JOURNAL OF NEUROSCIENCE
- Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity
- (2019) Wenjing Yi et al. BRAIN BEHAVIOR AND IMMUNITY
- Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
- (2018) Simon Faissner et al. CNS DRUGS
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Microglial control of astrocytes in response to microbial metabolites
- (2018) Veit Rothhammer et al. NATURE
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Therapies for Multiple Sclerosis
- (2018) Simon Faissner et al. Cold Spring Harbor Perspectives in Medicine
- IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
- (2018) Mónica Kurte et al. Frontiers in Immunology
- Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
- (2018) Jennifer Petrillo et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
- (2018) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
- (2017) Diego Cadavid et al. LANCET NEUROLOGY
- Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
- (2017) Dennis Chan et al. LANCET NEUROLOGY
- Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
- (2017) Simon Faissner et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Remyelination therapies: a new direction and challenge in multiple sclerosis
- (2017) Jason R. Plemel et al. NATURE REVIEWS DRUG DISCOVERY
- Pregabalin enhances myelin repair and attenuates glial activation in lysolecithin-induced demyelination model of rat optic chiasm
- (2017) Danyal Daneshdoust et al. NEUROSCIENCE
- Wellness and the Role of Comorbidities in Multiple Sclerosis
- (2017) Brandon P. Moss et al. Neurotherapeutics
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
- (2017) Luanne M. Metz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
- (2017) Simon Faissner et al. Nature Communications
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
- (2017) Simon Faissner et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
- (2016) Assunta Dal-Bianco et al. ACTA NEUROPATHOLOGICA
- Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
- (2016) Robert J. Fox et al. Contemporary Clinical Trials
- Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study
- (2016) P. S. Sørensen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis
- (2016) Joachim Burman et al. JOURNAL OF NEUROIMMUNOLOGY
- Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis
- (2016) Alice Valentin-Torres et al. Journal of Neuroinflammation
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- A polarizing question: do M1 and M2 microglia exist?
- (2016) Richard M Ransohoff NATURE NEUROSCIENCE
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE
- (2016) Helena Radbruch et al. Frontiers in Immunology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants
- (2015) Kevin Blauth et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler's Murine Encephalomyelitis
- (2015) Vanessa Herder et al. BRAIN PATHOLOGY
- Disease-modifying treatments for multiple sclerosis - a review of approved medications
- (2015) Ø. Torkildsen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
- (2015) Simon Zhornitsky et al. Journal of Neuroinflammation
- Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis
- (2015) Carine Savarin et al. Journal of Neuroinflammation
- Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS
- (2015) D. C. Joshi et al. JOURNAL OF NEUROSCIENCE
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
- (2015) EL MacMillan et al. Multiple Sclerosis Journal
- Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation
- (2015) Juan G. Zarruk et al. NEUROBIOLOGY OF DISEASE
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- Mitochondrial DNA sequence variation in multiple sclerosis
- (2015) Gregory J. Tranah et al. NEUROLOGY
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
- (2015) Claire M. Rice et al. Trials
- Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis
- (2015) Mahboobeh Fereidan-Esfahani et al. JAMA Neurology
- Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
- (2015) EL MacMillan et al. Multiple Sclerosis Journal
- B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
- (2015) Laure Michel et al. Frontiers in Immunology
- Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration
- (2015) Daniel May de Oliveira et al. INFLAMMOPHARMACOLOGY
- Early netrin-1 expression impairs central nervous system remyelination
- (2014) Vanja Tepavčević et al. ANNALS OF NEUROLOGY
- NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells
- (2014) Narasimhulu Simma et al. Cell Communication and Signaling
- Human CNS immune senescence and neurodegeneration
- (2014) Wolfgang J Streit et al. CURRENT OPINION IN IMMUNOLOGY
- Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules
- (2014) Robert P. Lisak et al. GLIA
- Tissue-Resident Memory T Cells
- (2014) Jason M. Schenkel et al. IMMUNITY
- Astrocyte galectin-9 potentiates microglial TNF secretion
- (2014) Andrew J Steelman et al. Journal of Neuroinflammation
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- N-Methyl-d-Aspartate Receptor Blockade Is Neuroprotective in Experimental Autoimmune Optic Neuritis
- (2014) Kurt-Wolfram Sühs et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
- (2014) Manabu Araki et al. Modern Rheumatology
- Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
- (2014) Lior Mayo et al. NATURE MEDICINE
- Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
- (2014) Feng Mei et al. NATURE MEDICINE
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Iron in multiple sclerosis: roles in neurodegeneration and repair
- (2014) Erin Stephenson et al. Nature Reviews Neurology
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- TNF and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype in the Injured Spinal Cord
- (2014) Antje Kroner et al. NEURON
- Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
- (2014) Catherine Diamante Sorbara et al. NEURON
- Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis
- (2014) Madeleine White et al. PLoS One
- Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain
- (2014) Grzegorz Sulkowski et al. PLoS One
- Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study
- (2014) Katrin Strassburger-Krogias et al. Therapeutic Advances in Neurological Disorders
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Second generation S1P pathway modulators: Research strategies and clinical developments
- (2013) Marc Bigaud et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
- (2013) Tarunya Arun et al. BRAIN
- Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
- (2013) David Paling et al. BRAIN
- Fibronectin aggregation in multiple sclerosis lesions impairs remyelination
- (2013) Josephine M. J. Stoffels et al. BRAIN
- Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases
- (2013) Ali Theibich et al. CLINICAL RHEUMATOLOGY
- Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis
- (2013) Grzegorz Sulkowski et al. JOURNAL OF NEUROIMMUNOLOGY
- A regenerative approach to the treatment of multiple sclerosis
- (2013) Vishal A. Deshmukh et al. NATURE
- M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
- (2013) Veronique E Miron et al. NATURE NEUROSCIENCE
- Pathophysiology of the brain extracellular matrix: a new target for remyelination
- (2013) Lorraine W. Lau et al. NATURE REVIEWS NEUROSCIENCE
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans
- (2013) Anders Tisell et al. PLoS One
- Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis
- (2012) Graham R. Campbell et al. ACTA NEUROPATHOLOGICA
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
- (2012) Ankita Mehta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
- (2012) Roberta Magliozzi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Iron Efflux from Astrocytes Plays a Role in Remyelination
- (2012) K. Schulz et al. JOURNAL OF NEUROSCIENCE
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
- (2012) Peter Connick et al. LANCET NEUROLOGY
- Oligodendroglia metabolically support axons and contribute to neurodegeneration
- (2012) Youngjin Lee et al. NATURE
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
- (2011) Sandra Vergo et al. BRAIN
- Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis
- (2011) Jessica L. Zambonin et al. BRAIN
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Oxidative damage in multiple sclerosis lesions
- (2011) L. Haider et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis
- (2011) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2011) Ivana Nikić et al. NATURE MEDICINE
- Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
- (2011) Olga V. Chechneva et al. NEUROBIOLOGY OF DISEASE
- Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
- (2010) Géraldine Androdias et al. ANNALS OF NEUROLOGY
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
- (2010) Graham R. Campbell et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis
- (2010) C M Rice et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Demyelination Increases Axonal Stationary Mitochondrial Size and the Speed of Axonal Mitochondrial Transport
- (2010) S. Kiryu-Seo et al. JOURNAL OF NEUROSCIENCE
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
- (2010) Maarten E. Witte et al. MITOCHONDRION
- Myelination and support of axonal integrity by glia
- (2010) Klaus-Armin Nave NATURE
- Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
- (2010) Y. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Mitochondrial changes within axons in multiple sclerosis
- (2009) D. J. Mahad et al. BRAIN
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
- (2009) Bernadette Pöllinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhanced number and activity of mitochondria in multiple sclerosis lesions
- (2009) Maarten E Witte et al. JOURNAL OF PATHOLOGY
- Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
- (2009) LM Metz et al. Multiple Sclerosis Journal
- Remyelination protects axons from demyelination-associated axon degeneration
- (2008) K. A. Irvine et al. BRAIN
- Mitochondrial defects in acute multiple sclerosis lesions
- (2008) Don Mahad et al. BRAIN
- Oligodendrocytes and myelination: The role of iron
- (2008) Bozho Todorich et al. GLIA
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
- Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status
- (2008) Stephen G Waxman Nature clinical practice. Neurology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search